Benefits of Omega-3 in Cancer Prevention

The omega-3 compound is made up of four fatty acids: EPA and DHA from fish and fish oils, ALA from flax and canola oils, and DPA from whale and seal oils. Clinical evidence supports the use of EPA and DHA from fish and fish oils for prostate, breast and colo-rectal cancer prevention, but shows no benefit for the use of DPA-related products, and an increased risk in advanced prostate cancer from the ALA form.

Omega-3 EPA and DHA are beneficial in prevention. On the treatment side, their role is unclear. However, it is clinically clear that those suffering from cancer are more susceptible to heart disease, weakened immune response, and other related inflammatory conditions, which omega-3 EPA and DHA do positively impact. By incorporating See Yourself Well™ EPA and DHA into a treatment plan, a patient will:

• reduce the risk of developing breast cancer by 26%
• reduce the risk of developing prostate cancer by 45%
• reduce the risk of developing colo-rectal cancer by 30%

  ---

Dosage: *

In order to capture all of the risk factors indicated above, the patient should consume 1.2 grams of combined See Yourself Well™

EPA and DHA omega-3 per day as follows:

• .2 of the 1,000mg capsules, OR

• .4 of the 500mg capsules, OR
• 1/4 teaspoon of the liquid oil

* Dosages are intended to cover all risk reductions listed and are based on 600mg or 60% EPA/DHA concentrate of 1 gram of fish oil.

Warning - Not All Omega 3s Are The Same:

Unless the Omega-3, which comes from. fish oil, is molecularly distilled, it contains high levels of hazardous contaminants such as mercury. See Yourself Well™ Professional Grade Omega-3 is ultra-refined and concentrated while providing premium quality and optimum health benefit. All See Yourself Well™  products are tested for compliance with the standards set by the Council for Responsible Nutrition and the World Health Organization and receive a 5-Star rating from the International Fish Oil Standards Program.

( Available for viewing at www.ifosprogram.com )

Berbert et ai, J. Of nutr., London State Univ. Brazil, 2005. Lopez-Garica et. AI., J. Nutr., 134: 1806-1811, 2004. Merchant et aI., AJCN., 82- 668-674, 2005. Lu et aI., Am. J. Epid., 161:948-959,2005. Miljanoiv et aI., AJCN. 82:887-893,2005. Mickleborough et al. Am J. Respir. Crit. Care Med., 2003. Peat et aI., J. Allergy Clin Immunology, 114(4):807813, 2004. Proc Natl Acad Sci USA. 2005 May 17;102(20):7133-8. Epub 2005 May 9. A. Richardson and P. Montgomery, Pediatrics, 115: 1360-1366, 2005. Yuen et aI., Epilepsy and Behaviour, 7:253-258, 2005. Whalley, et aI., AJCN, 80: 1650-1657, 2004. Hibbeln, NIH, 2005. Br J Cancer. 2003 Nov 3;89(9):1686-92. Augustsson et aI., Cancer Epid., Biomarkers, and Prev., 12: 64-67, 2003. Norat et aI., J. Natl. Cancer Inst., 97:906-16, 2005. Simon et ai, AJE, 1995, also AHA Statement, 2000. A.M. Gotto, Circ. 97:1027, 1998. Billman, GE, Proc. Natl. Acad. Sci. 1994. LeMaitre et aI., AJCN, 77:319, 2003. He et aI., Stroke, 35: 1358-1542, 2004. Holub BJ., CMAJ, 166:609-615, 2002.